Biliverdin reductase deficiency triggers an endothelial-to-mesenchymal transition in human endothelial cells

Damian Klóska; Aleksandra Kopacz; Aleksandra Piechota-Polańczyk; Christoph Neumayer; Ihor Huk; Jozef Dulak; Alicja Józkowicz; Anna Grochot‐Przeczek

doi:10.1016/j.abb.2019.108182

Related publications

Article2010

Overexpression of biliverdin reductase enhances resistance to chemotherapeutics

Urszula Florczyk, Sławomir Gołda, Agata Zieba, Jarosław Cisowski, Alicja Józkowicz, Jozef Dulak

Article2020

Valproic Acid Decreases Endothelial Colony Forming Cells Differentiation and Induces Endothelial-to-Mesenchymal Transition-like Process

Nathalie Névo, Nathalie Névo, Séverine Lecourt, Séverine Lecourt, Ivan Bièche, Ivan Bièche, Magda Kucia, Magda Kucia, Audrey Cras, Audrey Cras, Adeline Blandinières, Adeline Blandinières, Sophie Vacher, Sophie Vacher, Nicolas Gendron, Nicolas Gendron, Coralie L. Guérin, Coralie L. Guérin, Mariusz Z. Ratajczak, Mariusz Z. Ratajczak, David M. Smadja, David M. Smadja

Article2008

Biliverdin reductase: new features of an old enzyme and its potential therapeutic significance.

Urszula Florczyk, Alicja Józkowicz, Jozef Dulak

Article2003

HMG-CoA Reductase Inhibitors Regulate Inflammatory Transcription Factors in Human Endothelial and Vascular Smooth Muscle Cells

Wolfgang Dichtl, Jozef Dulak, Matthias Frick, Hannes Alber, Severin P. Schwarzacher, Mikko P.S. Ares, Jan Nilsson, Otmar Pachinger, Franz Weidinger

Article2012

Sulfation degree of glycosaminoglycans triggers distinct cytoskeleton organisation in mesenchymal stem cells

Diana Soares da Costa, Yali Yang, Stephanie Möller, Tobin Groth, Rui L Reis, Iva Pashkuleva